214 related articles for article (PubMed ID: 11434895)
1. Intermittent claudication: effective medical management of a common circulatory problem.
Beebe HG
Am J Cardiol; 2001 Jun; 87(12A):14D-18D. PubMed ID: 11434895
[TBL] [Abstract][Full Text] [Related]
2. A systematic review and economic evaluation of cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease.
Squires H; Simpson E; Meng Y; Harnan S; Stevens J; Wong R; Thomas S; Michaels J; Stansby G
Health Technol Assess; 2011 Dec; 15(40):1-210. PubMed ID: 22142554
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of cilostazol and other therapies for intermittent claudication.
Dawson DL
Am J Cardiol; 2001 Jun; 87(12A):19D-27D. PubMed ID: 11434896
[TBL] [Abstract][Full Text] [Related]
4. Treatment of intermittent claudication with pentoxifylline and cilostazol.
Tjon JA; Riemann LE
Am J Health Syst Pharm; 2001 Mar; 58(6):485-93; quiz 494-6. PubMed ID: 11286146
[TBL] [Abstract][Full Text] [Related]
5. Medical management of peripheral arterial disease.
Creager MA
Cardiol Rev; 2001; 9(4):238-45. PubMed ID: 11405904
[TBL] [Abstract][Full Text] [Related]
6. Cost effectiveness of cilostazol compared with naftidrofuryl and pentoxifylline in the treatment of intermittent claudication in the UK.
Guest JF; Davie AM; Clegg JP
Curr Med Res Opin; 2005 Jun; 21(6):817-26. PubMed ID: 15969881
[TBL] [Abstract][Full Text] [Related]
7. Management of patients with intermittent claudication.
Olin JW
Int J Clin Pract; 2002 Nov; 56(9):687-93. PubMed ID: 12469984
[TBL] [Abstract][Full Text] [Related]
8. Measuring treatment effects of cilostazol on clinical trial endpoints in patients with intermittent claudication.
Smith JA
Clin Cardiol; 2002 Mar; 25(3):91-4. PubMed ID: 11892686
[TBL] [Abstract][Full Text] [Related]
9. A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial.
Beebe HG; Dawson DL; Cutler BS; Herd JA; Strandness DE; Bortey EB; Forbes WP
Arch Intern Med; 1999 Sep; 159(17):2041-50. PubMed ID: 10510990
[TBL] [Abstract][Full Text] [Related]
10. A rational approach to diagnosis and treatment of intermittent claudication.
Fernandez BB
Am J Med Sci; 2002 May; 323(5):244-51. PubMed ID: 12018666
[TBL] [Abstract][Full Text] [Related]
11. Cilostazol for peripheral arterial disease.
Robless P; Mikhailidis DP; Stansby GP
Cochrane Database Syst Rev; 2007 Jan; (1):CD003748. PubMed ID: 17253494
[TBL] [Abstract][Full Text] [Related]
12. The role of cilostazol in the treatment of intermittent claudication.
Barnett AH; Bradbury AW; Brittenden J; Crichton B; Donnelly R; Homer-Vanniasinkam S; Mikhailidis DP; Stansby G
Curr Med Res Opin; 2004 Oct; 20(10):1661-70. PubMed ID: 15462700
[TBL] [Abstract][Full Text] [Related]
13. Cilostazol: treatment of intermittent claudication.
Reilly MP; Mohler ER
Ann Pharmacother; 2001 Jan; 35(1):48-56. PubMed ID: 11197586
[TBL] [Abstract][Full Text] [Related]
14. Cilostazol for peripheral arterial disease.
Robless P; Mikhailidis DP; Stansby GP
Cochrane Database Syst Rev; 2008 Jan; (1):CD003748. PubMed ID: 18254032
[TBL] [Abstract][Full Text] [Related]
15. Clinical manifestation of atherosclerotic peripheral arterial disease and the role of cilostazol in treatment of intermittent claudication.
Grouse JR; Allan MC; Elam MB
J Clin Pharmacol; 2002 Dec; 42(12):1291-8. PubMed ID: 12463722
[TBL] [Abstract][Full Text] [Related]
16. Pharmacotherapy for peripheral arterial disease: emerging therapeutic options.
Jaff MR
Angiology; 2002; 53(6):627-33. PubMed ID: 12463615
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of cilostazol and pentoxifylline on vascular endothelial growth factor in patients with intermittent claudication.
Lee TM; Su SF; Tsai CH; Lee YT; Wang SS
Clin Sci (Lond); 2001 Sep; 101(3):305-11. PubMed ID: 11524048
[TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapy of intermittent claudication.
Doggrell SA
Expert Opin Pharmacother; 2001 Nov; 2(11):1725-36. PubMed ID: 11825312
[TBL] [Abstract][Full Text] [Related]
19. Cilostazol: new drug. Intermittent claudication: too little efficacy, too many risks.
Prescrire Int; 2009 Apr; 18(100):56-9. PubMed ID: 19585717
[TBL] [Abstract][Full Text] [Related]
20. Evidence-based symptom relief of intermittent claudication: efficacy and safety of cilostazol.
Donnelly R
Diabetes Obes Metab; 2002 Mar; 4 Suppl 2():S20-5. PubMed ID: 12180354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
